- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Japanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
6
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
6 companies
ReproCELL
Market Cap: JP¥21.4b
Provides stem cell research and drug discovery services in Japan.
4978
JP¥215.00
7D
16.8%
1Y
47.3%
Mochida Pharmaceutical
Market Cap: JP¥103.1b
Manufactures and sells pharmaceuticals and healthcare products in Japan.
4534
JP¥2,954.00
7D
2.2%
1Y
-12.3%
Hisamitsu Pharmaceutical
Market Cap: JP¥280.6b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥3,914.00
7D
-2.4%
1Y
-1.0%
KYORIN Pharmaceutical
Market Cap: JP¥86.2b
Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.
4569
JP¥1,500.00
7D
0.9%
1Y
-13.2%
Zeria Pharmaceutical
Market Cap: JP¥90.4b
Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.
4559
JP¥2,066.00
7D
1.4%
1Y
-3.9%
Kaken Pharmaceutical
Market Cap: JP¥142.9b
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
4521
JP¥3,780.00
7D
0.3%
1Y
-6.9%